Companies · AI / ML

Intelligent Retinal Imaging Systems, Inc.

PENSACOLA · AI / ML · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Intelligent Retinal Imaging Systems, Inc. — recommendation, valuation, rhythm, risks.
$13.3M
Total raised · real
2
Rounds
0.5×
Latest step-up
Top 11%
Sector rank · raised
Series A
Latest stage · inferred · Fri Nov 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Intelligent Retinal Imaging Systems, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the ai/ml sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.77× the median modeled value of Series A AI / ML companies in 2019–2021 (48 peers) — value vs value, same stage and era.
  • Within the normal band (77% of peer median) for its niche.
Dormant
  • Last raise 6.6 yr ago; this sector typically re-raises about every 11 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in AI / ML

Intelligent Retinal Imaging Systems, Inc. is one of 2067 AI / ML companies tracked from PENSACOLA. By capital raised it ranks among the largest (ahead of 90% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
6
Investors (latest)
2017
Year incorporated
2019-11-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2017-06-15 Raised $9.0M (real) Modeled valuation $325M (est)$9.0M$325MSeries A2017Series A · 2019-11-15 Raised $4.3M (real) Modeled valuation $156M (est)$4.3M$156MSeries A2019+$4.3MCumulative $13M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$9.0M · 2017
Series A extension$4.3M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$156.2M
Base estimate est.
$5.8M
Conservative case
$849.4M
Upside case
$19.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the ai/ml sector profile. Directional, not a quoted figure.

Series A · modeled $325.2M · 2017-06-152017Series A · modeled $156.2M · 2019-11-152019
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
54%
Survival probability
29% low · 74% high
1.57×/yr
Annual markup
1.97×/yr upside case
6.0 yr
Elapsed time used
6.6 yr actual, capped for stale marks
ai/ml
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
29 mo
Avg between rounds
$5.5M/yr
Capital velocity
9.0 yr
On record since
2017
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.8× above median
This company$13.3M
Sector median$4.7M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.7× of median
This company$4.3M
Sector median$6.0M
Modeled value — vs sector median (estimate, all stages) 5.6× above median
This company$156.2M
Sector median$27.9M

Raised more than 90% of sector peers (real $). Modeled value above 91% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #36 of 48.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)TARA Intelligence Inc. · Series A Raised $12.6M · modeled $455.2M (est)Castle Intelligence, Inc. · Series A Raised $11.7M · modeled $423.4M (est)CrowdAI, Inc. · Series A Raised $10.1M · modeled $365.0M (est)Socrates AI, Inc. · Series A Raised $21.0M · modeled $361.3M (est)Roger.ai, Inc. · Series A Raised $9.6M · modeled $346.3M (est)Cohort Intelligence Corp · Series A Raised $11.5M · modeled $342.0M (est)Superb AI, Inc. · Series A Raised $11.5M · modeled $329.0M (est)Intelligencia Inc. · Series A Raised $13.8M · modeled $304.6M (est)Clearview AI, Inc. · Series A Raised $8.6M · modeled $299.5M (est)Resistant Ai, Inc. · Series A Raised $12.5M · modeled $294.3M (est)Sila Inc. · Series A Raised $10.7M · modeled $279.7M (est)Root AI, Inc. · Series A Raised $7.9M · modeled $276.2M (est)Intelligent Retinal Imaging Systems, Inc. (this company) Raised $13.3M · modeled $156.2M (est)Intelligent Retinal Imaging Systems, Inc.
CompanyStageRaised · realValue · estvs peer med.
TARA Intelligence Inc.Series A$12.6M$455.2M2.26×
Castle Intelligence, Inc.Series A$11.7M$423.4M2.10×
CrowdAI, Inc.Series A$10.1M$365.0M1.81×
Socrates AI, Inc.Series A$21.0M$361.3M1.79×
Roger.ai, Inc.Series A$9.6M$346.3M1.72×
Cohort Intelligence CorpSeries A$11.5M$342.0M1.70×
Superb AI, Inc.Series A$11.5M$329.0M1.63×
Intelligencia Inc.Series A$13.8M$304.6M1.51×
Clearview AI, Inc.Series A$8.6M$299.5M1.49×
Resistant Ai, Inc.Series A$12.5M$294.3M1.46×
Sila Inc.Series A$10.7M$279.7M1.39×
Root AI, Inc.Series A$7.9M$276.2M1.37×
Intelligent Retinal Imaging Systems, Inc. this companySeries A$13.3M$156.2M0.77×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$9.0M2017-06-15$40.9M$325.2M90%
Series A$4.3M2019-11-15$19.6M$156.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$9.0M2017-06-15
    • First recorded raise — entered as Series A.
    • 4 investors on this round.
  2. Series A$4.3M2019-11-15
    • Raised again after 29 mo — slower than the ~11 mo sector norm.
    • Round 2.1× smaller than the prior — bridge or down round.
    • 6 investors on this round.
Intelligence
2022 ~Q2
Modeled next raise · ~29mo cadence
$4.3M
Modeled next size est.range $4.3M$6.9M
0.5×
Last step-up
$5.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jason , Crawford5 other2017-06
Matt Rice4 other2017-06
Steve Martin3 other2019-11
Sunil Gupta1 other2017-06
Annette Ramsey2019-11
Jeff Stolte2017-06
Registry & provenance

Intelligent Retinal Imaging Systems, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1710877
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Basetwo Artificial Intelligence Inc.AI / MLSeries A$13.4M$72.4Msame sector · same stage
Glia AI, Inc.AI / MLSeries A$13.4M$47.9Msame sector · same stage
Guardforce AI Co., Ltd.AI / MLSeries A$13.2M$21.8Msame sector · same stage
Controlrooms.ai, Inc.AI / MLSeries A$13.4M$100.2Msame sector · same stage
Mesh Intelligent Technologies, Inc.AI / MLSeries A$13.5M$91.4Msame sector · same stage
GiXsystem.ai, Inc.AI / MLSeries A$13.5M$43.5Msame sector · same stage
Octane AI, Inc.AI / MLSeries A$13.1M$121.4Msame sector · same stage
Tackle Ai, LlcAI / MLSeries A$13.1M$19.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
RETINA-AI Health, Inc.AI / MLSeries A$40.9M92%
Intelligent Observation, Inc.AI / MLSeed$23.0M87%
Neural Analytics, Inc.AI / MLSeries B$258.0M84%
Perimeter Medical Imaging AI, Inc.AI / MLSeed$7.1M82%
Cohort Intelligence CorpAI / MLSeries A$342.0M82%
DOC.AI IncAI / MLSeed$101.0M81%
Ocular Science, Inc.Other Health CarePre-Seed$5.4M81%
Precision Image Analysis, Inc.Other Health CareSeed$60.6M81%
Frequently asked
How much funding has Intelligent Retinal Imaging Systems, Inc. raised?
Intelligent Retinal Imaging Systems, Inc. has raised approximately $13.3M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Intelligent Retinal Imaging Systems, Inc.'s estimated valuation?
Provath's modeled valuation for Intelligent Retinal Imaging Systems, Inc. is approximately $156.2M (modeled range $5.8M–$849.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Intelligent Retinal Imaging Systems, Inc. at?
Intelligent Retinal Imaging Systems, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Nov 15.
What does Intelligent Retinal Imaging Systems, Inc. do and where is it based?
Intelligent Retinal Imaging Systems, Inc. operates in the AI / ML sector, based in PENSACOLA.
Explore related

See where Intelligent Retinal Imaging Systems, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Intelligent Retinal Imaging Systems, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.